IRulya Therapeutics (IRLA) Research & Development (2018 - 2026)
IRulya Therapeutics (IRLA) posted Research & Development of $5.46 million for Q2 2026, down 16.7% from $6.55 million a year earlier and down 20.2% from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Research & Development (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at IRulya Therapeutics was $32.99 million, up 29.7% year-over-year; for FY2025, it came in at $35.38 million, up 90.3% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of -10.4% (FY2020 to FY2025).
- In prior years, IRulya Therapeutics' Research & Development was $18.59 million in FY2024 (+96.8%), $9.45 million in FY2023 (-62.5%), $25.18 million in FY2022 (-58.6%) and $60.8 million in FY2021 (-0.8%).
- The Q2 2026 figure stands as the lowest quarterly Research & Development since Q3 2024.
- On a year-over-year basis, Research & Development increased in six of the last eight quarters, with growth averaging 79.9%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2024, with growth of 243.5%; the weakest was Q3 2022, with a decline of 82.5%.
- According to Business Quant data, Research & Development for the three prior quarters was $6.85 million (Q1 2026), $12.6 million (Q4 2025) and $8.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 5.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.46 Mn |
| Mar 31, 2026 | 6.85 Mn |
| Dec 31, 2025 | 12.60 Mn |
| Sep 30, 2025 | 8.08 Mn |
| Jun 30, 2025 | 6.55 Mn |
| Mar 31, 2025 | 8.15 Mn |
| Dec 31, 2024 | 5.83 Mn |
| Sep 30, 2024 | 4.92 Mn |
| Jun 30, 2024 | 4.15 Mn |
| Mar 31, 2024 | 3.70 Mn |
| Dec 31, 2023 | 3.43 Mn |
| Sep 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | 1.35 Mn |
| Mar 31, 2023 | 3.23 Mn |
| Dec 31, 2022 | 7.20 Mn |
| Sep 30, 2022 | 2.45 Mn |
| Mar 31, 2022 | 12.76 Mn |
| Dec 31, 2021 | 15.21 Mn |
| Sep 30, 2021 | 14.04 Mn |
| Jun 30, 2021 | 14.72 Mn |
API Access
IRulya Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();